More FDA draws consequences for poor quality of hand disinfectants and UV Wands
More Data Integrity Problems as Main Topic of an FDA Warning Letter
More Nitrosamine Impurities: Extension of the Deadline for the Submission of Variation Applications
More FDA Warning Letter: No Stability Studies for Reworked Batches
More CTIS & EudraVigilance - Update for Sponsors of Clinical Trials
More FDA offers "Snapshot" Feature for Clinical and Development Guidelines
More New Ph. Eur. Chapter on Implementation of Pharmacopoeial Procedures
More New Edition of the Technical Guide for the Elaboration of Ph. Eur. Monographs
More New Questions and Answers from the EMA regarding Titanium Dioxide in Medicines